PRME vs. SPY
PRME (Prime Medicine Inc. Common Stock) is a stock, while SPY (State Street SPDR S&P 500 ETF) is S&P 500 fund tracking the S&P 500 Index. Over the past 3 years, PRME returned -41.59%/yr vs 22.64%/yr for SPY. At a 0.35 correlation, their price movements are largely independent.
Performance
PRME vs. SPY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PRME achieves a -7.49% return, which is significantly lower than SPY's 11.69% return.
PRME
- 1D
- -5.59%
- 1M
- -5.87%
- YTD
- -7.49%
- 6M
- -2.73%
- 1Y
- 169.75%
- 3Y*
- -41.59%
- 5Y*
- —
- 10Y*
- —
SPY
- 1D
- 0.14%
- 1M
- 5.40%
- YTD
- 11.69%
- 6M
- 12.09%
- 1Y
- 29.62%
- 3Y*
- 22.64%
- 5Y*
- 14.20%
- 10Y*
- 15.57%
PRME vs. SPY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
PRME Prime Medicine Inc. Common Stock | -7.49% | 18.84% | -67.04% | -52.31% | 20.88% |
SPY State Street SPDR S&P 500 ETF | 11.69% | 17.72% | 24.89% | 26.18% | 5.14% |
Correlation
The correlation between PRME and SPY is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2022 | 0.35 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PRME vs. SPY — Risk / Return Rank
PRME
SPY
PRME vs. SPY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Prime Medicine Inc. Common Stock (PRME) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PRME | SPY | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.72 | 2.52 | -0.81 |
Sortino ratioReturn per unit of downside risk | 2.64 | 3.42 | -0.78 |
Omega ratioGain probability vs. loss probability | 1.28 | 1.46 | -0.18 |
Calmar ratioReturn relative to maximum drawdown | 2.89 | 3.42 | -0.53 |
Martin ratioReturn relative to average drawdown | 4.78 | 15.93 | -11.14 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PRME | SPY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.72 | 2.52 | -0.81 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.84 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.87 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.39 | 0.59 | -0.98 |
Drawdowns
PRME vs. SPY - Drawdown Comparison
The maximum PRME drawdown since its inception was -94.55%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for PRME and SPY.
Loading charts...
Drawdown Indicators
| PRME | SPY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.55% | -55.19% | -39.36% |
Max Drawdown (1Y)Largest decline over 1 year | -59.52% | -8.88% | -50.64% |
Max Drawdown (3Y)Largest decline over 3 years | -93.26% | -18.76% | -74.50% |
Max Drawdown (5Y)Largest decline over 5 years | — | -24.50% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.72% | — |
Current DrawdownCurrent decline from peak | -84.80% | 0.00% | -84.80% |
Average DrawdownAverage peak-to-trough decline | -65.30% | -9.05% | -56.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.96% | 1.91% | +34.05% |
Volatility
PRME vs. SPY - Volatility Comparison
Prime Medicine Inc. Common Stock (PRME) has a higher volatility of 21.23% compared to State Street SPDR S&P 500 ETF (SPY) at 2.75%. This indicates that PRME's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PRME | SPY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.23% | 2.75% | +18.48% |
Volatility (6M)Calculated over the trailing 6-month period | 53.61% | 8.89% | +44.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 99.54% | 11.81% | +87.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 89.79% | 17.05% | +72.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 89.79% | 17.94% | +71.85% |
Dividends
PRME vs. SPY - Dividend Comparison
PRME has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 0.97%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRME Prime Medicine Inc. Common Stock | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPY State Street SPDR S&P 500 ETF | 0.97% | 1.07% | 1.21% | 1.40% | 1.65% | 1.20% | 1.52% | 1.75% | 2.04% | 1.80% | 2.03% | 2.06% |
Frequently Asked Questions
PRME and SPY have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PRME has higher volatility (21.23%) compared to SPY (2.75%). In terms of maximum drawdown, PRME dropped -94.55% vs SPY's -55.19%.
SPY currently has the higher Sharpe Ratio (2.52 vs 1.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PRME and SPY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer